BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:     

Vena Cava Filters

Vena Cava Filters


New and more advanced Retrievable Vena Cava Filters have recently been developed and introduced resulting in renewed growth and change of dynamics in this established market.

The majority of traditional Permanent Vena Cava Filters were placed after failure of anticoagulation to prevent pulmonary embolism (PE). With over 1.2 million PE cases diagnosed in the US & Europe every year and over 300,000 related deaths, medical needs were under-served.

The introduction of Retrievable Vena Cava Filters has expanded the indication space. Now, more than half of the filters are placed prophylactically for the prevention of PE. This is expanding the current market for Vena Cava Filters and pushing growth rates back to double digit levels.

Medtech Ventures' Vena Cava Filters - Technology & Market Forecast report gives an overview of the state of both the technology and the market. It profiles the current market landscape and explores the market potential with global forecasts to 2010.

The report details many pressing issues in the space including current approved and in-development devices and the realignment of leading players market shares.

Order Report

With Vena Cava Filters - Technology & Market Forecast you will be better able to:

1. Understand current market dynamics, competitors positions and market shares.

2. Identify emerging technologies and the companies behind them.

3. Leverage your own technology and brain storm new business opportunities.

4. Assess market size and growth potential.

5. Monitor the competition's marketed and in-development products.

6. Investigate mergers, acquisitions and licensing possibilities.

7. Assess market potential and have access to forecasts till 2010.

Vena Cava Filters - Technology & Market Forecast gives a short but thorough analysis of the current situation and growth trends of the global market for these devices. It is targeted at busy medtech executives & venture capitalists scanning for windows of opportunities opening in the endovascular space.

Published: July 2005

Pages: 20

PDF Format
Table of Contents
Price: $1,040.00 / GBP520.00



Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.

Back to top